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Background: The aim of this study is to determine sex differences in long-term outcome after coronary
artery bypass grafting (CABG).
Methods: The international randomized controlled IMAGINE study included 2553 consecutive patients
with a left ventricular ejection fraction of >40% who underwent isolated CABG. Median follow-up was 32
months (IQR 17e42 months). The composite endpoint comprised of death, myocardial infarction (MI),
cerebrovascular event, angina, revascularization and congestive heart failure. Cox regression analysis was
used to examine sex differences in outcome post-CABG.
Results: Of the 2553 patients, 2229 were men and 324 (13%) were women. Women were older and more
often reported diabetes and hypertension. Smoking and impaired renal function were more prevalent in
men. Women experienced a higher event rate during follow-up (composite endpoint 18% vs 12%;
P ¼ 0.007). Cox regression showed an increased risk of the composite endpoint in women after
adjustment for age (HR 1.48 (95% CI: 1.11e1.97)) which was non-signiﬁcant after additional adjustment
for other confounders (HR 1.26 (95% CI: 0.92e1.72)).
Conclusion: Women have a worse long-term outcome after CABG than men in univariate analysis.
However, after adjusting for potential confounders female sex became a non-signiﬁcant predictor for
prognosis, possibly due to the small sample size of women. Deﬁnite answers regarding sex-differences in
long-term outcome after CABG should come from future pooling of studies comprising a larger number
of women.
© 2015 Elsevier Ireland Ltd. All rights reserved.1. Introduction
Coronary artery disease (CAD) is the main cause of death in
women older than 65 years [1]. In 2008 the prevalence of cardio-
vascular disease in the United States was 35.0% in women
compared to 37.4% in men. However age-adjusted mortality rates
were higher in women, namely 51.7% versus 48.3% [1]. Previous, University Medical Center
Utrecht, The Netherlands.
jema).
rved.studies suggest sex differences in treatment and prognosis of CAD,
but many discrepancies exist between different studies [2e16]. It
remains uncertainwhether these differences in outcome are due to
a different risk burden between men and women or whether fe-
male sex is an independent risk factor of worse outcome and
prognosis. Age is a major confounder, as younger, but not older,
women have a higher mortality rate than men after myocardial
infarction with or without intervention [17e19]. Furthermore,
women undergo coronary angiography or percutaneous coronary
intervention less often as compared to men [19e21]. The inﬂuence
of female sex on the outcome after coronary artery bypass grafting
(CABG) remains unclear, as previous studies are contradictory
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term outcome after CABG, data from the Ischemia Management
with Accupril post-bypass Graft via inhibition of the coNverting
Enzyme (IMAGINE) were analysed. IMAGINE is a multicentre, in-
ternational randomized controlled trial with extensive data con-
cerning baseline characteristics and operational techniques.Table 1
Baseline characteristics.
Men
(n ¼ 2229)
Women
(n ¼ 324)
P-value
Age, years (SD) 60 ± 10 65 ± 10 <0.01
Median follow-up in months (IQR) 32 (17e42) 32 (15e42) 0.212. Methods
2.1. Patient characteristics
The design and the main results of the Ischemia Management
with Accupril post-bypass Graft via Inhibition of the coNverting
Enzyme (IMAGINE) trial have been previously described in detail
[22,23]. In brief, the IMAGINE trial is an international, randomized,
double-blind, placebo-controlled, multicentre study that investi-
gated whether early administration of an angiotensin-converting
enzyme (ACE) inhibitor after CABG reduced cardiovascular
events compared to placebo in stable patients. Patients older than
18 years with a left ventricular ejection fraction (LVEF) of 40%
who were stable after CABG were included. Exclusion criteria
consisted of intolerance or contraindication to ACE inhibitors,
insulin-dependent diabetes, concomitant cardiac surgery, serious
concomitant disease including severe renal impairment, signiﬁ-
cant perioperative myocardial infarction, pregnancy and investi-
gational drug use <30 days. The 2553 patients included in this
study between 1999 and 2004 were randomly assigned to qui-
napril 10e20 mg (n ¼ 1280) or to placebo (n ¼ 1273). On average
patients were randomized 4 ± 2 days after CABG, with a maximum
of 7 days (10 days in France). The primary endpoint was a com-
posite of time to ﬁrst occurrence of cardiovascular death or
resuscitated cardiac arrest, nonfatal myocardial infarction, coro-
nary revascularization, unstable angina, stroke and congestive
heart failure that required hospitalization. Five patients were lost
to follow-up (0.2%).
For the current analyses all available follow up time was used.
The ethics committees of all participating institutions approved the
research protocol and all patients gave written informed consent.Medical history
Myocardial infarction 40 (887) 35 (114) 0.11
CABG 3 (58) 2 (6) 0.42
Percutaneous coronary intervention 17 (388) 21 (67) 0.15
Peripheral vascular disease 7 (151) 9 (30) 0.10
Stroke/TIA 1 (33) 1 (4) 0.73
Cardiovascular risk factors
LDL cholesterol (mmol/L) (SD) 2.9 ± 1 2.9 ± 1 0.95
Diabetes 10 (212) 13 (41) 0.08
HbA1c (mmol/mol) (SD) 39 ± 8 41 ± 32 <0.01
Systolic blood
pressure (mmHg) (SD)
121 ± 14 124 ± 15 0.11
Current or former smoker 74 (1658) 52 (167) <0.01
Family history of coronary
artery disease
67 (1480) 73 (235) 0.03
Body surface area (m2) (SD) 2.0 ± 0.2 1.8 ± 0.2 <0.01
Heart rate (bpm) (SD) 82 ± 13 81 ± 12 0.23
Left ventricular ejection
fraction (%) (SD)
60 ± 7 61 ± 10 0.43
MDRD (estimated GFR
based on creatinine) (SD)
63 ± 15 108 ± 32 <0.01
Medication
Acetylsalicylic acid (ASA) 74 (1567) 72 (205) 0.44
Betablockers 78 (1657) 79 (224) 0.92
Calcium-channel blockers 767 (36) 107 (38) 0.67
Diuretics 9 (184) 9 (25) 0.97
ACE inhibitors 21 (433) 19 (54) 0.55
Statins 65 (1384) 60 (172) 0.09
Continuous variables are presented as mean ± SD; categorical variables are pre-
sented as percentages (n)SD, standard deviation; IQR, inter quartile range; LDL, low-
density lipoprotein; MDRD, modiﬁcation of diet in renal disease; GFR, glomerular
ﬁltration rate.2.2. Statistical analysis
Patients were stratiﬁed by sex. Baseline categorical variables are
presented as percentages (numbers). Differences between sexes
were calculated by ChieSquare test. Continuous variables are
described as the mean value ± standard deviation (SD) if normally
distributed or the median value if the distribution was skewed.
Possible differences were tested by t-test. All statistical tests were
two-sided using p < 0.05 as level of signiﬁcance. The primary
endpoint was evaluated using a Cox proportional hazard model
where men served as the reference category. Results are expressed
as hazard ratios (HR) with 95% conﬁdence intervals (95% CI). To
identify possible confounders all baseline characteristics and sur-
gical characteristics were related to the composite endpoint sepa-
rately, adjusted for age. Correlation with the determinant sex was
evaluated by a Pearson's correlation chi-square in variables that
were signiﬁcantly associated with the composite endpoint. Those
with a p-value <0.1 at Pearson's correlation chi-square, as well as
age and sex, were added in the multivariate model. Since previous
studies demonstrated that body surface area (BSA) is associated
with a worse outcome post-CABG in female sex we used BSA
instead of body mass index [13,14]. Because of the well-
documented surgical characteristics, a subanalysis was made
regarding the type of grafts used during CABG. All statistical ana-
lyses were performed using SPSS Version 21.0.3. Results
3.1. Patient characteristics
Out of the 2553 included patients 324 (13%) were women.
Median follow-up was 32 months in both men and women (IQR
17e42 in men, IQR 15e42 in women). Baseline characteristics are
shown in Table 1. Women were on average 5 years older than men
and more often reported hypertension and a family history of CAD.
Men more often smoked and revealed decreased renal function (all
P < 0.01).
3.2. Characteristics of CABG
On average men received more grafts (3.3 versus 3.0 in women;
P < 0.01) (see Table 2). The percentage of off-pump CABG compared
to CABG on cardiopulmonary bypass did not differ between men
and women (18% versus 21%, P ¼ 0.19). Furthermore, there was no
difference in complete revascularization, deﬁned as all vessels
>1 mm with a stenosis >70% having been bypassed, between
women and men (P ¼ 0.21).
3.3. Endpoint
Womenweremore likely to experience the composite endpoint,
18% versus 12% in men (P < 0.01), as shown in Table 3. This dif-
ference is mainly driven by the distribution of unstable angina (5%
in women vs 1.9% in men), coronary revascularization (1.2% in
women vs 0.4% in men) and congestive heart failure (2.5% in
women vs 0.9% in men).
Table 2
Surgical characteristics.
Patient characteristics % (n) Men
(n ¼ 2229)
Women
(n ¼ 324)
P-value
Off-pump CABG 18 (407) 21 (69) 0.19
Number of grafts 3.3 ± 1.1 3.0 ± 1.1 <0.01
Use of LIMA 95 (2120) 92 (297) 0.01
Use of RIMA 19 (415) 9 (28) <0.01
Use of free IMA 3 (61) 6 (18) <0.01
Use of other arterial grafts 20 (445) 10 (31) <0.01
Use of saphenous vein 79 (1757) 79 (257) 0.84
Endarterectomy 6 (111) 8 (22) 0.21
Complete revascularization 88 (1962) 90 (293) 0.21
Continuous variables are presented as mean ± SD; categorical variables are pre-
sented as percentages (n).
CABG, coronary artery bypass grafting; Free artery bypass, composite of radial ar-
tery, all other arteries than LIMA or RIMA; IMA, internal mammary artery; LIMA, left
internal mammary artery; mixed grafts, arterial or venous grafts; RIMA, right in-
ternal mammary artery.
Fig. 1. Cox survival plot. Cox survival plot for composite endpoints in women and men.
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composite endpoint in women compared to men after adjustment
for age with an HR of 1.48 (95%CI 1.11e1.97). Seven other variables
were after adjustment for age associated with the composite
endpoint, family history of CAD (HR 1.36 (95%CI: 1.06e1.74)), a
medical history of PCI (HR 1.65 (95%CI: 1.28e2.11)), CABG (HR 2.28
(95%CI: 1.39e3.72)) or peripheral vascular disease (HR 1.80 (95%CI:
1.30e2.51)), BSA (HR 0.61 (95%CI: 0.38e0.98)), complete revascu-
larization (HR 0.63 (95%CI: 0.48e0.85)) and number of grafts used
(HR 0.78 (95%CI 0.71e0.87)). Of these seven variables only a family
history of CAD (P ¼ 0.03), number of grafts (P < 0.01) and BSA
(P < 0.01) correlated with sex and were added to the multivariate
model (Fig. 1). Female sex was not associated with the composite
endpoint in the multivariate analysis (HR 1.26 (95%CI: 0.92e1.72),
Fig. 1) nor was BSA (HR 0.74 (95%CI: 0.45e1.23). A family history of
CAD remained associated with the composite endpoint (HR 1.35
(95%CI: 1.05e1.73)) as well as number of grafts used (HR 0.79 (95%
CI: 0.72e0.88)).
In the original IMAGINE trial, there were no differences in the
incidence of the primary endpoint between the quinapril and pla-
cebo group after subdividing by sex.4. Discussion
The current study demonstrates that women have an increased
risk of an adverse outcome after CABG compared to men during 2.5
years of follow-up. However, in the multivariate analysis female sex
is not an independent predictor for developing the composite
endpoint in this cohort potentially due to lack of power. At baselineTable 3
Composite endpoint.
Patient characteristics Men
(n ¼ 2229)
Women
(n ¼ 324)
P-value
Composite endpoint 12 (273) 18 (57) <0.01
Cardiovascular death 0.8 (17) 1.2 (4)
Myocardial infarction (non-fatal) 1 (22) 1.2 (4)
Documented angina (not req. hosp.) 6.1 (137) 6.2 (20)
Unstable angina (req. hosp.) 1.9 (43) 5 (15)
Coronary revascularization 0.4 (9) 1.2 (4)
Stroke 1.0 (23) 0.3 (1)
Resuscitation or cardiac arrest 0.1 (2) 0.3 (1)
Congestive heart failure (req. hosp.) 0.9 (20) 2.5 (8)
Categorical variables are presented as percentages (n).
MDRD, estimated GFR based on creatinine; Req. hosp., requiring hospitalization;
TIA, transient ischemic attack.women were older and more often had hypertension, a family his-
tory of CAD and a smaller BSA. On the other handmen smokedmore
often and had more frequently renal dysfunction. In regard to other
studies both men and women included in the IMAGINE trial re-
ported a relatively low burden of cardiovascular risk factors. Inter-
estingly, our results showed no differences in percentage of off-
pump CABG between men and women and no beneﬁt of off-pump
CABG for the composite endpoint in both men and women. Previ-
ous studies showed an increased risk of adverse outcome inwomen
for CABG on cardiopulmonary bypass, compared to off-pump CABG
[4e8,10,14]. The majority of prior studies included emergency
CABGs whereas we excluded these unstable patients, which makes
it difﬁcult to directly compare results [4e8,10e15]. Furthermore, we
used a composite endpoint where others used death as primary
outcome. Some studies showed an increased risk inwomen for early
mortality [2,8,10], but the majority found no sex differences
[3,4,12e15]. Others only found an increased risk for mortality in
women after CABG on cardiopulmonary bypass and not after off-
pump CABG [5e7,11,16]. The higher risk in women we found in the
univariate analysis is caused primarily by a higher rate of unstable
angina and coronary revascularization as the number of deaths was
equal in both sexes. This is consistent with the ﬁnding in this study
that the number of grafts used is signiﬁcant between women and
men in the multivariate analysis. The difference in univariate anal-
ysis between women and men could therefore point towards a
difference in coronary artery diameter: as women are smaller, they
have smaller coronary arteries that are technicallymore demanding
in CABG. Indeed, BSA was a confounding factor in this study.
5. Limitations
Main limitation of this study is the small sample size of women.
Women comprised only 13% of our study population compared to
24% on average in other studies [2e8,10e16]. Unfortunately no
screenings log, with numbers screened patients and the reason of
exclusion, is available so the low inclusion rate in women remains
elusive. One of the possible explanations is the exclusion of patients
with severe comorbidities, as women are known to be more
severely impaired. The sample size of women introduces an un-
expected power problem in themultivariate model, where sex does
not seem to associatewith the composite endpoint whereas the cox
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Our results are only applicable to stable patients undergoing
CABG since unstable patients were excluded from the study, just as
patients with a clinical need for ACE-inhibitors (e.g. severe renal
insufﬁciency and insulin dependent diabetes). We are to our
knowledge the ﬁrst study to include only stable patients and since a
large part of the CABG population is stable before surgery, it is
relevant to investigate sex differences in outcome in this subpop-
ulation. It could be that sex differences are still present in the un-
stable group.
Echocardiography testing for diastolic dysfunction which may
eventually evolve in to heart failure with preserved ejection frac-
tion (HFpEF) was not performed. As diastolic dysfunction is com-
mon in the general population [24] more prevalent among women
undergoing cardiac surgery [25] and associated with worse
outcome in CAD patients [26], this could be a confounding factor.
Also, no data were available on relief of angina symptoms, one of
the indications for CABG surgery. However, we do not think this
affected the results, since persisting angina was well-documented.
The difference between women and men found in this study
was mainly due to differences in ‘soft’ endpoints such as unstable
angina and cardiac revascularization, rather than more robust
endpoints such as death. As these ‘soft’ endpoints are more prone
to misclassiﬁcation, this could potentially have induced non-
differential (more in women) misclassiﬁcation of the outcome.
Unfortunately, this type of bias is difﬁcult to overcome and may
have overestimated the sex difference.
The duration of follow-up was limited to 2.5 years. Although the
majority of the present studies had a limited follow-up of 30 days
after CABG [2,4,6,7,10e15], some have shown a decrease in the sex
gap after long-term follow-up [3,27], as described earlier by M
Claassen et al. [28]. Future studies should examine a larger number
of women during long-term follow-up. For example, an individual
participant data analysis of current studies could improve the po-
wer to detect sex-speciﬁc differences and their determinants in
outcome between women and men after CABG.
6. Conclusion
Women have a worse long-term outcome after CABG than men
in univariate analysis. However, after adjusting for potential con-
founders female sex became a non-signiﬁcant predictor for prog-
nosis, possibly due to the small sample size of women. Deﬁnite
answers regarding sex-differences in long-term outcome after
CABG should come from future pooling of studies comprising a
larger number of women.
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